On 4/30/2024, TransMedics Group (TMDX) reported earnings of $0.35 per share on revenue of $96.85 million for the first quarter ended March 2024. The consensus estimate was a loss of $0.05 per share on revenue of $83.32 million.
Fundamental Analysis

Exención de responsabilidad